ArticleFrontiers in oncology2020
Prediction of Response to Preoperative Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Using Multicenter CT-Based Radiomic Analysis.
Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 40 citations in OpenAlex.
- Pretreatment prognostic nutritional index and immune status for response to preoperative neoadjuvant chemotherapy in cervical squamous cell carcinoma: an exploratory retrospective study.Frontiers in oncology · 2026Article
- Pre-Treatment PET Radiomics for Prediction of Disease-Free Survival in Cervical Cancer.Cancers · 2025Article
- Application of artificial intelligence in assisting treatment of gynecologic tumors: a systematic review.Visual computing for industry, biomedicine, and art · 2025Review
- Delta-radiomics analysis based on magnetic resonance imaging to identify radiation proctitis in patients with cervical cancer after radiotherapy.Frontiers in oncology · 2025Article
- Development and validation of aBMC cancer · 2024Article
- Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy.Scientific reports · 2023Article
- Photon-counting detector CT-based virtual monoenergetic reconstructions: repeatability and reproducibility of radiomics features of an organic phantom and human myocardium.European radiology experimental · 2023Article
- Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.Diagnostics (Basel, Switzerland) · 2023Article
- An MRI-based machine learning radiomics can predict short-term response to neoadjuvant chemotherapy in patients with cervical squamous cell carcinoma: A multicenter study.Cancer medicine · 2023Article
- A Deep Learning Radiomics Nomogram to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer: A Two-Center Study.Diagnostics (Basel, Switzerland) · 2023Article
- Development and validation of radiomic signature for predicting overall survival in advanced-stage cervical cancer.Frontiers in nuclear medicine · 2023Article
- Post treatment imaging in patients with local advanced cervical carcinoma.Frontiers in oncology · 2022Review
- Radiomics in surgical oncology: applications and challenges.Computer assisted surgery (Abingdon, England) · 2021Review
- Virtual Monoenergetic Images of Dual-Energy CT-Impact on Repeatability, Reproducibility, and Classification in Radiomics.Cancers · 2021Article
- Radiomics in cervical and endometrial cancer.The British journal of radiology · 2021Review
- Application of full-field organ dose modulation on cervical- thoraco-abdominopelvic contrast-enhanced computed tomography.Japanese journal of radiology · 2021Article
- Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer.Frontiers in oncology · 2021Article
- Predicting Response to Systemic Chemotherapy for Advanced Gastric Cancer Using Pre-Treatment Dual-Energy CT Radiomics: A Pilot Study.Frontiers in oncology · 2021Article
- Cohort Profile: Chinese Cervical Cancer Clinical Study.Frontiers in oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.